Home > Notice-board > Official notices >
Alterations to the Byelaws: supplementary prescribing

Search

The Pharmaceutical Journal
Vol 271 No 7270 p529
11 October 2003


Alterations to the Byelaws: supplementary prescribing

NOTICE is hereby given in accordance with Section XXVIII of the Byelaws that the Council of the Society has approved proposals to alter Sections I and II of the Byelaws and the Third Schedule to the Byelaws as hereunder and that it intends to make such alterations after the expiry of 60 days from the date of this notice, subject to such amendments as the Lords of the Privy Council may require.

SECTION I: PRELIMINARY
In paragraph 2, after the definition of “student” there shall be inserted:

“Supplementary Prescriber” means a pharmacist who holds a Practice Certificate in Supplementary Prescribing approved by the Council and who having paid the required fee and satisfied the Registrar that all conditions have been complied with has the annotation “sp” against his name in the Register signifying that he is qualified to order drugs, medicines and appliances as a Supplementary Prescriber.”

SECTION II: MEMBERS
At the end, there shall be inserted:

8. A pharmacist who makes application to the Registrar to be recognised as a Supplementary Prescriber
(a) shall produce evidence to satisfy the Registrar that he holds a Practice Certificate in Supplementary Prescribing approved by the Council; and
(b) shall pay to the Society a fee of £35*,
whereupon the Registrar, being satisfied that all conditions have been complied with, shall annotate the Register of Pharmaceutical Chemists to signify that he is qualified to order drugs, medicines and appliances as a Supplementary Prescriber (Section XXI paragraph 5).
* Or such other amount as the Privy Council may approve

THIRD SCHEDULE: THE ANNUAL REGISTER OF PHARMACEUTICAL CHEMISTS
At the end, add:

“sp indicates that a pharmacist is qualified to order drugs, medicines and appliances as a Supplementary Prescriber.”

ANN LEWIS
Secretary and Registrar

Note: The effect of the Byelaw amendment is to allow pharmacists who becomes supplementary prescribers to have that qualification recognised by an annotation to the annual Register of Pharmaceutical Chemists on payment of a one-off fee. The reference to Section XXI paragraph 5 relates to a proposed new paragraph concerned with Register annotations that is currently awaiting approval by the Privy Council (PJ, 15 February, p251).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal